Indexing metadata

The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2

Dublin Core PKP Metadata Items Metadata for this Document
1. Title Title of document The parameters of long-term humoral immunity induced by a single injection of the Sputnik Light vaccine among non-infected volunteers and those infected with SARS-CoV-2
2. Creator Author's name, affiliation, country F. M. Izhaeva; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country A. I. Tukhvatulin; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country A. S. Dzharullaeva; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country I. V. Dolzhikova; Россия
2. Creator Author's name, affiliation, country O. V. Zubkova; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country D. V. Shcheblyakov; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country N. L. Lubenets; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country E. A. Smolyarchuk; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University); Россия
2. Creator Author's name, affiliation, country T. G. Zubkova; Eco-Safety Medical Center; Россия
2. Creator Author's name, affiliation, country A. S. Erokhova; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country I. М. Cherenkova; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country К. М. Bukhtin; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country O. Popova; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country N. M. Tukhvatulina; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country B. S. Naroditsky; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Россия
2. Creator Author's name, affiliation, country D. Y. Logunov; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University); Россия
2. Creator Author's name, affiliation, country A. L. Gintsburg; N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University); Россия
3. Subject Discipline(s)
3. Subject Keyword(s) COVID-19; SARS-CoV-2; vaccines; Sputnik Light; vaccine-induced antibody response; serum maturation; hybrid immunity
4. Description Abstract

Although the immunogenicity of clinically approved COVID-19 vaccines remains under intensive investigation, little is still known about the parameters of long-term immune responses. In this paper, we present for the first time the parameters of humoral immunity studied in the phase 1–2 open-label clinical trial of the Sputnik Light vaccine, with a special focus on late follow-up time points (90 and 180 days). For the most accurate assessment of the parameters of humoral post-vaccination immunity (titer and avidity index of antigen-specific antibodies against the RBD domain of SARS-CoV-2), we conducted an additional analysis that allowed us to triage volunteers with immunity formed only in response to vaccination, as well as those with hybrid immunity (infected with SARS-CoV-2 before and after vaccination). The findings indicate that single-shot vaccination with the Sputnik Light vaccine induces a durable (seroconversion 73% on day 180) and mature humoral immunity. Natural immunization as a result of the SARS-CoV-2 infection leads to significant changes in the studied parameters of post-vaccination immunity.

5. Publisher Organizing agency, location Acta Naturae Ltd
6. Contributor Sponsor(s) The Russian Direct Investment Fund
PJSC "Sberbank" (682)
"Human Vaccine" LLC
7. Date (DD-MM-YYYY) 22.04.2025
8. Type Status & genre Peer-reviewed Article
8. Type Type Research Article
9. Format File format
10. Identifier Uniform Resource Identifier https://actanaturae.ru/2075-8251/article/view/27529
10. Identifier Digital Object Identifier (DOI) 10.32607/actanaturae.27529
11. Source Title; vol., no. (year) Acta Naturae; Vol 17, No 1 (2025)
12. Language English=en en
13. Relation Supp. Files Fig. 1. Trial profile and stratification of volunteers into groups (1MB) doi: 10.32607/20758251-2025-17-1-52-63-132053
Fig. 2. Titer of RBD-specific IgG antibodies in volunteers vaccinated with the Sputnik Light vaccine. (781KB) doi: 10.32607/20758251-2025-17-1-52-63-132054
Fig. 3. Titer of RBD-specific IgG1 and IgG4 antibodies in volunteers vaccinated with Sputnik Light. (568KB) doi: 10.32607/20758251-2025-17-1-52-63-132055
Fig. 4. The avidity index of RBD-specific IgG antibodies in volunteers vaccinated with Sputnik Light. (787KB) doi: 10.32607/20758251-2025-17-1-52-63-132056
Fig. 5. Correlation between the titer and the avidity index of RBD-specific IgG antibodies. (486KB) doi: 10.32607/20758251-2025-17-1-52-63-132057
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
15. Rights Copyright and permissions Copyright (c) 2025 Izhaeva F.M., Tukhvatulin A.I., Dzharullaeva A.S., Dolzhikova I.V., Zubkova O.V., Shcheblyakov D.V., Lubenets N.L., Smolyarchuk E.A., Zubkova T.G., Erokhova A.S., Cherenkova I.М., Bukhtin К.М., Popova O., Tukhvatulina N.M., Naroditsky B.S., Logunov D.Y., Gintsburg A.L.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.